rs372553453
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBP6_Very_Strong
The NM_006946.4(SPTBN2):c.3707G>A(p.Arg1236His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000279 in 1,614,024 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000092 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000021 ( 0 hom. )
Consequence
SPTBN2
NM_006946.4 missense
NM_006946.4 missense
Scores
1
4
14
Clinical Significance
Conservation
PhyloP100: 1.39
Publications
0 publications found
Genes affected
SPTBN2 (HGNC:11276): (spectrin beta, non-erythrocytic 2) Spectrins are principle components of a cell's membrane-cytoskeleton and are composed of two alpha and two beta spectrin subunits. The protein encoded by this gene (SPTBN2), is called spectrin beta non-erythrocytic 2 or beta-III spectrin. It is related to, but distinct from, the beta-II spectrin gene which is also known as spectrin beta non-erythrocytic 1 (SPTBN1). SPTBN2 regulates the glutamate signaling pathway by stabilizing the glutamate transporter EAAT4 at the surface of the plasma membrane. Mutations in this gene cause a form of spinocerebellar ataxia, SCA5, that is characterized by neurodegeneration, progressive locomotor incoordination, dysarthria, and uncoordinated eye movements. [provided by RefSeq, Dec 2009]
SPTBN2 Gene-Disease associations (from GenCC):
- autosomal recessive spinocerebellar ataxia 14Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Orphanet
- spinocerebellar ataxia type 5Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.19145131).
BP6
Variant 11-66699475-C-T is Benign according to our data. Variant chr11-66699475-C-T is described in CliVar as Likely_benign. Clinvar id is 586478.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66699475-C-T is described in CliVar as Likely_benign. Clinvar id is 586478.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66699475-C-T is described in CliVar as Likely_benign. Clinvar id is 586478.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66699475-C-T is described in CliVar as Likely_benign. Clinvar id is 586478.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66699475-C-T is described in CliVar as Likely_benign. Clinvar id is 586478.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66699475-C-T is described in CliVar as Likely_benign. Clinvar id is 586478.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66699475-C-T is described in CliVar as Likely_benign. Clinvar id is 586478.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66699475-C-T is described in CliVar as Likely_benign. Clinvar id is 586478.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66699475-C-T is described in CliVar as Likely_benign. Clinvar id is 586478.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66699475-C-T is described in CliVar as Likely_benign. Clinvar id is 586478.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66699475-C-T is described in CliVar as Likely_benign. Clinvar id is 586478.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66699475-C-T is described in CliVar as Likely_benign. Clinvar id is 586478.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66699475-C-T is described in CliVar as Likely_benign. Clinvar id is 586478.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66699475-C-T is described in CliVar as Likely_benign. Clinvar id is 586478.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66699475-C-T is described in CliVar as Likely_benign. Clinvar id is 586478.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66699475-C-T is described in CliVar as Likely_benign. Clinvar id is 586478.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66699475-C-T is described in CliVar as Likely_benign. Clinvar id is 586478.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152148Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
14
AN:
152148
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000517 AC: 13AN: 251478 AF XY: 0.0000589 show subpopulations
GnomAD2 exomes
AF:
AC:
13
AN:
251478
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461876Hom.: 0 Cov.: 31 AF XY: 0.0000261 AC XY: 19AN XY: 727244 show subpopulations
GnomAD4 exome
AF:
AC:
31
AN:
1461876
Hom.:
Cov.:
31
AF XY:
AC XY:
19
AN XY:
727244
show subpopulations
African (AFR)
AF:
AC:
8
AN:
33480
American (AMR)
AF:
AC:
1
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26136
East Asian (EAS)
AF:
AC:
0
AN:
39700
South Asian (SAS)
AF:
AC:
8
AN:
86258
European-Finnish (FIN)
AF:
AC:
0
AN:
53408
Middle Eastern (MID)
AF:
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
11
AN:
1112006
Other (OTH)
AF:
AC:
3
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152148Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74310 show subpopulations
GnomAD4 genome
AF:
AC:
14
AN:
152148
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
74310
show subpopulations
African (AFR)
AF:
AC:
13
AN:
41432
American (AMR)
AF:
AC:
0
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5194
South Asian (SAS)
AF:
AC:
1
AN:
4834
European-Finnish (FIN)
AF:
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
0
AN:
68030
Other (OTH)
AF:
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
3
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Mar 26, 2018
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
May 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Pathogenic
DEOGEN2
Benign
T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M
PhyloP100
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
D;D;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.